AFP and hepatocellular carcinoma: In contrast to these prior investigations, our multi-center and multi-stage validation is the first to evaluate the diagnostic value of BIRC5 autoantibody specifically in ANHCC and its complementary role alongside AFP diagnosis for HCC.